InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Helash Kevin, Chief Executive Officer. Director active across 2 companies, notably MARRONE BIO INNOVATIONS INC. Cumulatively, 7 filings have been recorded. The latest transaction was filed on 7 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€98,680178,831 shares@ €0.551824.8% of flow
Common Stock
SEC:0001209191-22-020079:0·
€98,680178,831 shares@ €0.551865.9% of flow
Common Stock
SEC:0001209191-22-008138·
€98,680178,831 shares@ €0.551824.8% of flow
Common Stock
SEC:0001209191-22-008138:0·
€42,81647,000 shares@ €0.91128.6% of flow
Common Stock
SEC:0001209191-21-053129·
€42,81647,000 shares@ €0.91110.8% of flow
Common Stock
SEC:0001209191-21-053129:0·
€8,1926,795 shares@ €1.20565.5% of flow
Common Stock
SEC:0001209191-21-036194·
€8,1926,795 shares@ €1.20562.1% of flow
Common Stock
SEC:0001209191-21-036194:0·
7 of 7 declarations
About Helash Kevin
Kevin Helash is the Chief Executive Officer of Marrone Bio Innovations Inc. In this role, he is responsible for the strategic and operational leadership of the company. Kevin Helash plays a key role in developing new biological solutions and optimizing the company's performance. His expertise in biotechnology and management is essential for the success of Marrone Bio Innovations.
